NGEN
NervGen Pharma Corp.
1.80$
+1.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in CAD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -0.04 | -0.32 | -0.20 | -0.21 | -0.33 | -0.19 | -0.25 | -0.27 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | 0.05 | 0.10 | 0.09 | 0.07 | |
| 0.01 | 0.01 | 0.04 | 0.01 | 0.04 | 0.00 | 0.01 | 0.01 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.13 | 0.39 | 0.24 | 0.50 | 0.43 | 0.01 | 0.34 | 0.33 | |
| 0.09 | 0.07 | 0.05 | 0.29 | 0.08 | -0.17 | 0.07 | 0.07 | |
| -0.04 | -0.32 | -0.20 | -0.21 | -0.34 | -0.19 | -0.25 | -0.27 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.